Skip to content Skip to footer
Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022

Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022

Shots:Dr. Vivek talked about the results from the preclinical study of its probiotic and herbal supplement for lung health in a poster presented at DDW 2022He also spoke about how resB helps to decrease MMP-9 inflammatory pathway activity, associated with tissue damage and neutrophilic inflammationThe interview provides a deep understanding of Resbiotic’s…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]